Market revenue in 2023 | USD 127.9 million |
Market revenue in 2030 | USD 268.8 million |
Growth rate | 11.2% (CAGR from 2023 to 2030) |
Largest segment | Serum-free media |
Fastest growing segment | Serum-free Media |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Serum-free Media, Classical Media, Stem Cell Culture Media, Chemically Defined Media, Specialty Media, Other Cell Culture Media |
Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, BD, STEMCELL Technologies, PromoCell GmbH |
Serum-free media was the largest segment with a revenue share of 36.51% in 2023. Horizon Databook has segmented the Italy cell culture media market based on serum-free media, classical media, stem cell culture media, chemically defined media, specialty media, other cell culture media covering the revenue growth of each sub-segment from 2018 to 2030.
In the past few years, the Italian biotechnology industry has witnessed significant growth due to tremendous academic and industrial research. According to the data published by International Trade Administration (ITA), in August 2019, R&D investments in biotechnology sector amounted to around USD 2 billion. Such high investments in biotechnology are expected to fuel the adoption of cell culture media for several research applications in the country.
Furthermore, increasing demand for more effective treatments for conditions, such as cancer, is driving the cancer research & biopharmaceutical industry in Italy. This is boosting the demand for cell culture media products. Furthermore, stem cell therapy is becoming increasingly controversial in Italy owing to government rulings on unproven stem cell therapy.
Presence of investors, such as Sofinnova Partners, which provide seed funding for gene therapy companies, is driving the market. For instance, in July 2021, the company invested USD 6.78 million (EUR 6 million) in gene therapy firms. It invested over USD 22 million in 2021 in other gene therapy companies. This increase in R&D in gene therapy segment is expected to drive the growth of cell culture media market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account